A phase Ib/II study of niraparib combination therapies for the treatment of metastatic castration-resistant prostate cancer (NCT03431350) Meeting Abstract
| Authors: | Subudhi, S. K.; Aparicio, A.; Zurita, A. J.; Doger, B.; Kelly, W. K.; Peer, A.; Rathkopf, D. E.; Karsh, L. I.; Tryon, J. J.; Kothari, N.; Zhao, X.; Zhu, E.; Ricci, D. S.; Tran, N.; De Bono, J. S. |
| Abstract Title: | A phase Ib/II study of niraparib combination therapies for the treatment of metastatic castration-resistant prostate cancer (NCT03431350) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 309s |
| Language: | English |
| ACCESSION: | WOS:000487345803366 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS5087 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS5087 -- Source: Wos |
